ICD 10 CM M11.17 | Description & Clinical Information
ICD 10 M11.17 describes a genetic condition known as familial chondrocalcinosis, which is characterized by the accumulation of calcium pyrophosphate dihydrate crystals in the cartilage of the ankle and foot joints, leading to calcification and progressive damage to the affected joint.
Official Description Of M11.17
The ICD 10 CM book defines ICD 10 code M11.17 as:
When To Use M11.17
The diagnosis describes by the ICD-10-CM M11.17 code is Familial Chondrocalcinosis of the ankle and foot. This is a rare genetic condition that can cause pain, swelling, stiffness, tenderness, and restricted movement of the joint. It affects the joints by causing calcium pyrophosphate dihydrate crystal deposits within the cartilage and soft tissues.
Patients with Familial Chondrocalcinosis may experience symptoms that can be similar to those of gout or osteoarthritis. However, this condition has a genetic component which means that it is more likely to affect patients who have a family history of the disease.
To diagnose Familial Chondrocalcinosis, healthcare providers start with obtaining a thorough medical history, performing a physical exam, and ordering imaging techniques such as X-rays. Laboratory examination of synovial fluid samples can also help to confirm the presence of crystals.
The treatment options for Familial Chondrocalcinosis are aimed at managing the symptoms and decreasing the risk of complications. Resting the affected joint, physical therapy, the use of supportive devices such as splints, and the administration of corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs) can provide relief from pain and inflammation.
In some cases, aspiration of joint fluid can help to remove crystals from the joint, reducing the chance of further damage. The use of colchicine, a medication that can help to prevent the formation of crystals, may also be prescribed. In rare cases where joint damage is severe, surgical repair may be necessary to correct the issue.
It’s important for patients with Familial Chondrocalcinosis to communicate with their healthcare provider about any changes in symptoms or the development of new ones. This can help to ensure that the right treatment plan is pursued, and that patients can effectively manage their condition.
While Familial Chondrocalcinosis is not curable, with proper treatment and management of symptoms, patients can maintain a good quality of life. It is essential for medical coders to accurately document the patient’s medical history, physical examination findings, and treatment plan to ensure that the medical claims are properly coded and billed. This documentation also contributes to quality patient care, which is an essential part of delivering effective healthcare.
